Market Tracker

12/19 6:05pm ET

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.24
Data as of Dec 19
 -0.007 / -2.83%
Today’s Change
0.22
Today|||52-Week Range
0.55
-9.43%
Year-to-Date

Today’s Trading

Previous close0.25
Today’s open0.24
Day’s range0.24 - 0.25
Volume882,244
Average volume (3 months)1,738,223
Market cap$48.0M
Dividend yield--
Data as of 4:03pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)+16.67%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)-29.58%
P/E ratioNM
Price/Sales295.61
Price/Book1.38

Competitors

 Today’s
change
Today’s
% change
CTRVContraVir Pharmaceut...0.000.00%
ENZNEnzon Pharmaceutical...-0.02-1.90%
AVEOAveo Pharmaceuticals...+0.04+4.94%
OGXIOncoGenex Pharmaceut...-0.25-10.96%
Data as of 3:59pm ET, 12/19/2014

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$150.0K
Annual profit (last year)-$16.2M
Net profit margin-10,816.67%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, Chief Executive Officer &
CSO
William A. Carter
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts